Search results for "Immune system"

showing 10 items of 2885 documents

Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2 d Haplotype

2001

ABSTRACT The importance of CD8 T cells for the control of cytomegalovirus (CMV) infection has raised interest in the identification of immunogenic viral proteins as candidates for vaccination and cytoimmunotherapy. The final aim is to determine the viral “immunome” for any major histocompatibility complex class I molecule by antigenicity screening of proteome-derived peptides. For human CMV, there is a limitation to this approach: the T cells used as responder cells for peptide screening are usually memory cells that have undergone in vivo selection. On this basis, pUL83 (pp65) and pUL123 (IE1 or pp68 to -72) were classified as immunodominant proteins. It is an open question whether this li…

MuromegalovirusAdoptive cell transferAntigenicityImmunologyCD8-Positive T-LymphocytesBiologymedicine.disease_causeMajor histocompatibility complexMicrobiologyImmediate-Early ProteinsViral Matrix ProteinsMiceOpen Reading FramesViral ProteinsImmune systemVirologymedicineAnimalsCytotoxic T cellAntigens ViralMice Inbred BALB CH-2 AntigensCytomegalovirusHerpesviridae InfectionsPhosphoproteinsVirologyPeptide FragmentsHaplotypesInsect ScienceProteomeImmunologybiology.proteinPathogenesis and ImmunityFemaleImmunologic MemorySpleenCD8Journal of Virology
researchProduct

Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral c…

1998

Effective control by the immune system is a hallmark of cytomegalovirus (CMV) infection. Accordingly, human CMV disease is a medical problem restricted to the immunologically immature or immunocompromised host (for a review, see reference 21). Murine models have implicated natural killer (NK) cells and CD8 T cells in the control of CMV infection. While NK cells mediate early protection in genetically resistant mouse inbred strains (4, 5, 31, 51), CD8 T cells establish enduring protective memory and function as principal antiviral effectors in susceptible strains (31). Specifically, in the BALB/c strain, major histocompatibility complex (MHC) class I-restricted antiviral CD8 T cells resolve …

MuromegalovirusAdoptive cell transferImmunologyViral Pathogenesis and ImmunityBone Marrow CellsImmunodominanceVirus ReplicationMajor histocompatibility complexMicrobiologyImmediate-Early ProteinsMiceImmune systemAntigenVirologyMHC class IAnimalsCytotoxic T cellLungAntigen PresentationMice Inbred BALB CbiologyImmunodominant EpitopesAntigen processingvirus diseasesHerpesviridae InfectionsVirologyKineticsInsect ScienceImmunologyTrans-Activatorsbiology.proteinFemaleT-Lymphocytes Cytotoxic
researchProduct

In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: Facts and thoughts based on murine models

2010

Cytomegaloviruses (CMVs) co-exist with their respective host species and have evolved to avoid their elimination by the hosts' immune effector mechanisms and to persist in a non-replicative state, known as viral latency. There is evidence to suggest that latency is nevertheless a highly dynamic condition during which episodes of viral gene desilencing, which can be viewed as incomplete reactivations, cause intermittent antigenic activity that stimulates CD8 memory-effector T cells and drives their clonal expansion. These T cells are supposed to terminate reactivation before completion of the productive viral cycle. In this view, CMVs do not "evade" their respective host's immune response bu…

MuromegalovirusCancer ResearchT cellAntigen presentationReceptors Antigen T-CellCytomegalovirusCD8-Positive T-LymphocytesBiologyMiceImmune systemAntigenVirologyVirus latencymedicineAntigenic variationAnimalsCytotoxic T cellViral InterferenceImmune EvasionAntigen PresentationHistocompatibility Antigens Class IHerpesviridae Infectionsmedicine.diseaseVirologyVirus LatencyDisease Models AnimalInfectious Diseasesmedicine.anatomical_structureCytomegalovirus InfectionsImmunologyVirus ActivationVirus Research
researchProduct

The Putative Natural Killer Decoy Early Genem04(gp34) of Murine Cytomegalovirus Encodes an Antigenic Peptide Recognized by Protective Antiviral CD8 T…

2000

ABSTRACTSeveral early genes of murine cytomegalovirus (MCMV) encode proteins that mediate immune evasion by interference with the major histocompatibility complex class I (MHC-I) pathway of antigen presentation to cytolytic T lymphocytes (CTL). Specifically, them152gene product gp37/40 causes retention of MHC-I molecules in the endoplasmic reticulum (ER)-Golgi intermediate compartment. Lack of MHC-I on the cell surface should activate natural killer (NK) cells recognizing the “missing self.” The retention, however, is counteracted by them04early gene product gp34, which binds to folded MHC-I molecules in the ER and directs the complex to the cell surface. It was thus speculated that gp34 mi…

MuromegalovirusGenes ViralImmunologyAntigen presentationchemical and pharmacologic phenomenaGenome ViralCD8-Positive T-LymphocytesMajor histocompatibility complexMicrobiologyImmediate-Early ProteinsGene productMiceViral ProteinsImmune systemAntigenPeptide LibraryVirologyAnimalsCytotoxic T cellHistocompatibility Antigen H-2DAntigens ViralCells CulturedGlycoproteinsMice Inbred BALB CMembrane GlycoproteinsbiologyHistocompatibility Antigens Class IH-2 AntigensVirologyKiller Cells NaturalCTL*Insect Sciencebiology.proteinPathogenesis and ImmunityFemaleCarrier ProteinsPeptidesCD8T-Lymphocytes CytotoxicJournal of Virology
researchProduct

Processing and Presentation of Murine Cytomegalovirus pORFm164-Derived Peptide in Fibroblasts in the Face of All Viral Immunosubversive Early Gene Fu…

2002

ABSTRACTCD8 T cells are the principal effector cells in the resolution of acute murine cytomegalovirus (mCMV) infection in host organs. This undoubted antiviral and protective in vivo function of CD8 T cells appeared to be inconsistent with immunosubversive strategies of the virus effected by early (E)-phase genesm04,m06, andm152. The so-called immune evasion proteins gp34, gp48, and gp37/40, respectively, were found to interfere with peptide presentation at different steps in the major histocompatibility complex (MHC) class I pathway of antigen processing and presentation in fibroblasts. Accordingly, they were proposed to prevent recognition and lysis of infected fibroblasts by cytolytic T…

MuromegalovirusImmunologyAntigen presentationMajor histocompatibility complexMicrobiologyImmediate-Early ProteinsMiceOpen Reading FramesViral ProteinsImmune systemAntigenVirologyMHC class IAnimalsCytotoxic T cellAntigens ViralGenes Immediate-EarlyCells CulturedAntigen PresentationMice Inbred BALB CMembrane GlycoproteinsbiologyAntigen processingFibroblastsVirologyPeptide FragmentsCTL*Insect Sciencebiology.proteinPathogenesis and ImmunityFemaleT-Lymphocytes CytotoxicJournal of Virology
researchProduct

The Immune Evasion Paradox: Immunoevasins of Murine Cytomegalovirus Enhance Priming of CD8 T Cells by Preventing Negative Feedback Regulation▿

2008

ABSTRACTCytomegaloviruses express glycoproteins that interfere with antigen presentation to CD8 T cells. Although the molecular modes of action of these “immunoevasins” differ between cytomegalovirus species, the convergent biological outcome is an inhibition of the recognition of infected cells. In murine cytomegalovirus, m152/gp40 retains peptide-loaded major histocompatibility complex class I molecules in acis-Golgi compartment, m06/gp48 mediates their vesicular sorting for lysosomal degradation, and m04/gp34, although not an immunoevasin in its own right, appears to assist in the concerted action of all three molecules. Using the Ld-restricted IE1 epitope YPHFMPTNL in the BALB/c mouse m…

MuromegalovirusImmunologyAntigen presentationPriming (immunology)Genome ViralBiologyCD8-Positive T-LymphocytesMajor histocompatibility complexVirus ReplicationMicrobiologyEpitopeImmediate early proteinImmediate-Early ProteinsEpitopesMiceViral ProteinsImmune systemAntigenVirologyCytotoxic T cellAnimalsAntigen PresentationMice Inbred BALB CHerpesviridae InfectionsKiller Cells NaturalInsect ScienceImmunologybiology.proteinPathogenesis and ImmunityFemaleLymph NodesImmunologic MemorySpleen
researchProduct

Tumor Control in a Model of Bone Marrow Transplantation and Acute Liver-Infiltrating B-Cell Lymphoma: an Unpredicted Novel Function of Cytomegalovirus

2002

ABSTRACTTumor relapse and cytomegalovirus (CMV) infection are major concerns in the therapy of hematopoietic malignancies by bone marrow transplantation (BMT). Little attention so far has been given to a possible pathogenetic interplay between CMV and lymphomas. CMV inhibits stem cell engraftment and hematopoietic reconstitution. Thus, by causing maintenance of bone marrow aplasia and immunodeficiency, CMV could promote tumor relapse. Alternatively, CMV could aid tumor remission. One might think of cytopathogenic infection of tumor cells, induction of apoptosis or inhibitory cytokines, interference with tumor cell extravasation or tumor vascularization, or bystander stimulation of an antitu…

MuromegalovirusLymphoma B-CellCD30ImmunologyBone Marrow AplasiaBiologyMicrobiologyMiceImmune systemhemic and lymphatic diseasesVirologyTumor Cells CulturedmedicineAnimalsCytotoxic T cellB-cell lymphomaBone Marrow TransplantationMice Inbred BALB CTumor Necrosis Factor-alphamedicine.diseaseLymphomaDisease Models AnimalHaematopoiesisLiverInsect ScienceCytomegalovirus InfectionsImmunologyPathogenesis and ImmunityStem cellJournal of Virology
researchProduct

Identification of a Kd-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84

2000

The two sister cytomegaloviruses (CMVs), human and murine CMV, have both evolved immune evasion functions that interfere with the major histocompatibility complex class I (MHC-I) pathway of antigen processing and presentation and are effectual in the early (E) phase of virus gene expression. However, studies on murine CMV have shown that E-phase immune evasion is leaky. An E-phase protein involved in immune evasion, namely m04-gp34, was found to simultaneously account for an antigenic peptide presented by the MHC-I molecule Dd. Recent work has demonstrated the induction of protective immunity specific for the E-phase protein M84-p65, one of two murine CMV homologues of the human CMV matrix …

MuromegalovirusPeptideBiologyMajor histocompatibility complexImmediate-Early ProteinsMiceOpen Reading FramesImmune systemVirologyAnimalsAmino Acid SequenceLymphocyte CountAntigens ViralGenes Immediate-EarlyGeneAntigenic peptidechemistry.chemical_classificationMice Inbred BALB CViral matrix proteinAntigen processingH-2 AntigensVirologyMolecular biologyPeptide FragmentschemistryCytomegalovirus earlybiology.proteinImmunologic MemoryT-Lymphocytes CytotoxicJournal of General Virology
researchProduct

Early gene m18, a novel player in the immune response to murine cytomegalovirus

2002

The identification of all antigenic peptides encoded by a pathogen, its T cell ‘immunome’, is a research aim for rational vaccine design. Screening of proteome-spanning peptide libraries or computational prediction is used to identify antigenic peptides recognized by CD8 T cells. Based on their high coding capacity, cytomegaloviruses (CMVs) could specify numerous antigenic peptides. Yet, current evidence indicates that the memory CD8 T cell response in a given haplotype is actually focused on a few viral proteins. CMVs actively interfere with antigen processing and presentation by the expression of immune evasion proteins. In the case of murine CMV (mCMV), these proteins are effectual in th…

MuromegalovirusT cellMolecular Sequence DataCD8-Positive T-LymphocytesBiologyVirus ReplicationVirusImmediate-Early ProteinsMiceImmune systemVirologymedicineAntigenic variationAnimalsCytotoxic T cellAntigens ViralGeneCells CulturedBase SequenceAntigen processingFibroblastsVirologymedicine.anatomical_structureViral replicationPeptidesImmunologic MemoryJournal of General Virology
researchProduct

P.20.3 Targeting fibrosis and inflammation in Duchenne Muscular Dystrophy

2013

Duchenne Muscular Dystrophy is the most frequent genetic muscle disease worldwide affecting ∼1:5000 male births. It is caused by a defective DMD gene, which leads to reduced and defective dystrophin protein expression. The constant breakdown of fibres leads to focal necrosis, myophagocytosis and a considerable influx of inflammatory cells into the muscle tissue, which is followed by increasing endomysial fibrosis. Both, inflammation and fibrosis as well as a putative relation are not yet understood immunologically. Fibrosis directly correlates with adverse outcome and early loss of ambulation. We have studied how inflammation is linked to fibrosis in DMD, with an emphasis on the communicati…

Muscle biopsymedicine.diagnostic_testbiologyDuchenne muscular dystrophyInflammationDiseasemedicine.diseasePhenotypeImmune systemNeurologyFibrosisPediatrics Perinatology and Child HealthImmunologymedicinebiology.proteinNeurology (clinical)medicine.symptomDystrophinGenetics (clinical)Neuromuscular Disorders
researchProduct